Continuous Local Intra-arterial Nimodipine Administration in Severe Symptomatic Vasospasm After Subarachnoid Hemorrhage
Authors:
- Christian MusahlCMChristian Musahl
- Hans HenkesHHHans Henkes
- Zsolt VajdaZVZsolt Vajda
- Jan CoburgerJCJan Coburger
- Nikolai HopfNHNikolai Hopf
- 1 June 2011
- journal article
- case report
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 68 (6) , 1541-1547
Abstract
Cerebral vasospasm (CV) is a potentially disastrous consequence of subarachnoid hemorrhage despite medical treatment. Nimodipine is a potent drug for vessel relaxation, but side effects may preclude a sufficient dose. To explore whether continuous local intra-arterial nimodipine administration (CLINA) can reverse vasospasm and prevent delayed ischemic neurological deficit. Six consecutive subarachnoid hemorrhage patients (5 women; mean age, 47.2 years) with severe CV despite maximum medical therapy underwent CLINA within 2 hours after the onset of clinical symptoms. After anticoagulation, microcatheters were inserted distally in the concerning supra-aortic vessels. Glyceryl trinitrate injection (2 mg) was followed by CLINA (nimodipine 0.4 mg/h for 70-147 hours). Duration of CLINA was determined by neurological status, transcranial Doppler sonography, and partial tissue oxygen pressure values. In all patients, neurological deficits improved or partial tissue oxygen pressure values returned to normal and transcranial Doppler sonography confirmed a reduced blood flow velocity within 12 hours. Magnetic resonance imaging showed no ischemic lesion caused by CV. Neurological outcome was good (modified Rankin Scale score, 0-2) in 3 patients, whereas 1 patient had a moderate clinical outcome (modified Rankin Scale score, 3-4) and 2 patients had a poor outcome (modified Rankin Scale score, 5) because of the SAH. Preliminary data show that CLINA is a straightforward, effective, and safe option for patients with severe CV refractory to medical therapy. Dilation of spastic arteries starts within a few hours and is lasting. Indication for CLINA is peripheral and diffuse CV at any location.Keywords
This publication has 24 references indexed in Scilit:
- Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experienceJournal of Neurosurgery, 2010
- ANGIOGRAPHIC AND HEMODYNAMIC EFFECT OF HIGH CONCENTRATION OF INTRA-ARTERIAL NICARDIPINE IN CEREBRAL VASOSPASMNeurosurgery, 2008
- THE IMPACT OF BALLOON ANGIOPLASTY ON THE EVOLUTION OF VASOSPASM-RELATED INFARCTION AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGENeurosurgery, 2008
- Milrinone for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageStroke, 2008
- High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 2008
- Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhageJournal of Neurosurgery, 1989
- Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.Stroke, 1987
- Changes in cerebral blood flow and metabolism following intraarterial or local administration of nimodipine, before and after experimental subarachnoid hemorrhage in baboons.Stroke, 1986
- Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.Stroke, 1985
- Treatment of Ischemic Deficits from Vasospasm with Intravascular Volume Expansion and Induced Arterial HypertensionNeurosurgery, 1982